The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies

Richard Pötter(Medical University of Vienna), Ina M. Jürgenliemk‐Schulz(University Medical Center Utrecht), Bhavana Rai(Post Graduate Institute of Medical Education and Research), Umesh Mahantshetty(Homi Bhabha National Institute), Peter Hoskin(University of Manchester), Dietmar Georg(Medical University of Vienna), Yvette Seppenwoolde(Comprehensive Cancer Center Vienna), Remi A. Nout(Erasmus MC Cancer Institute), Tamara Rumpold(Comprehensive Cancer Center Vienna), Fleur Huang(University of Alberta), Jacob Christian Lindegaard(Aarhus University Hospital), Kjersti Bruheim(Oslo University Hospital), Kathrin Kirchheiner(Comprehensive Cancer Center Vienna), Astrid de Leeuw(University Medical Center Utrecht), C. Nomden(University Medical Center Utrecht), Lars Fokdal(Aarhus University Hospital), Barbara Šegedin(Institute of Oncology Ljubljana), Alina Sturdza(Comprehensive Cancer Center Vienna), Christine Haie-Méder(Institut Gustave Roussy), Supriya Chopra(Tata Memorial Hospital), Kari Tanderup(Aarhus University), Christian Kirisits(Comprehensive Cancer Center Vienna), Marianne S. Assenholt(Aarhus University Hospital), N. Nesvacil(Comprehensive Cancer Center Vienna), Li Tee Tan(Xi'an Jiaotong University), Erik Van Limbergen, Israël Fortin(Comprehensive Cancer Center Vienna), Max Schmid(Comprehensive Cancer Center Vienna), Nina Boje Kibsgaard Jensen(Aarhus University Hospital), Uulke A. van der Heide(Radboud University Nijmegen)
Clinical and Translational Radiation Oncology
January 11, 2018
Cited by 932


Related Papers